Now that I have your attention, I would like to point out two pieces that, if you do not read them and at least attempt to engage with their analysis, will cause reasonable people to henceforth dismiss you when you make blanket claims about the ethics and the efficacy of steroid use in baseball:
- Eric Walker’s comprehensive analysis of the ethics, health risks and, most importantly, performance effects of steroids and other performance enhancing drugs, with copious references to the relevant scientific literature on the subject; and
OK, I’ll cut you slack if you don’t read the entirety of Walker’s piece. It’s long, it’s difficult, the page design kind of sucks and it’s not exactly as engaging as detective novel. But at the very least read Posnanski’s overview and then at least explore Walker’s piece here and there to test some of the assertions.
For those of you who don’t plan on doing either, at least take away this much: essentially none of the claims people make about what is so “obvious” about PED use are, in fact, obvious. Yes, there are still ethical hazards — and, of course, rule breaking — associated with PED use by ballplayers, but such things (a) are not as hazardous as we are led to believe; and (b) PED use does not logically and inevitably lead to the conclusions you so often hear about home runs and other hitting records being fraudulent.
Posnanski in particular makes some excellent points about the history of baseball juicing — as opposed to baseball player juicing — that seem like a far more obvious source of the new home run marks. And as I and so many others have said so many times, the fact that the home run boom came around the same time as large-scale expansion and a spate of cozy, home run-friendly ballparks coming online is criminally underplayed when the subject of home runs and baseball comes up.
I know that many of you don’t care what anyone says about these subjects and that you’ll continue to call all of the home run marks of the past 15 years fraudulent or worse. Just know that if you do, such arguments will be (a) counter to the empirical evidence; and (b) a function of your willful ignorance on the matter.
I do my best to limit the discussion of religion and politics on this blog. If you ignore the relevant data on PEDs and baseball and still spout off about it, however, you’re essentially arguing religion and politics.
It was reported on Friday that Yankees right-hander Masahiro Tanaka isn’t sure if he’ll be ready for Opening Day as he makes his way back from arthroscopic surgery to remove a bone spur from his right elbow. His health will be crucial to the Yankees’ chances this season, but the same goes for rotation-mate Michael Pineda, who hopes that this is the year he’ll be able to take on the workload of a frontline starter.
Pineda was on pace for a career-high in innings last season, but he landed on the disabled list in late July with a right flexor forearm muscle strain and missed a month. He struggled upon his return and ended up with 160 2/3 innings, so he fell short of his career-high of 171 innings as a rookie with the Mariners way back in 2011. Now going into his age-27 season, Pineda told Bryan Hoch of MLB.com that his goal for 2016 is to reach 200 innings for the first time in his career.
“For me, this year, I’m coming here early to be strong and working hard to pitch 200 innings this year,” Pineda said at the club’s Minor League complex. “I want to throw 200 innings this year. This is my goal, and help my team.”
Pineda had a mediocre 4.37 ERA (90 ERA+) last season despite impressive peripherals with 8.7 K/9 and 1.2 BB/9. Among pitchers with at least 160 innings pitched, only Bartolo Colon of the Mets had a lower walk percentage. Pineda managed to increase his ground ball rate to 48.2 percent and also saw an uptick in velocity from 2014, so there’s reason to believe in improvement if he can stay healthy.
The Brewers acquired prospects Jake Nottingham and Bubba Derby from the Athletics on Friday in exchange for slugging outfielder Khris Davis. The hope is that Nottingham will develop into the Brewers’ catcher of the future, so you could say that the club is planning for life after Jonathan Lucroy. However, Brewers general manager David Stearns said today that the trade doesn’t change Lucroy’s immediate status.
The Brewers are in rebuild-mode and Lucroy is an excellent trade chip if healthy, as his contract includes a $5.25 million club option for 2017. It’s likely just a matter of time before he’s shipped elsewhere, but yesterday’s trade shouldn’t change the timeline for a potential deal. Nottingham doesn’t turn 21 until April and has yet to play in Double-A, so he’s still a ways off from the majors. The Brewers can afford to wait on the right offer for Lucroy, whether it’s in spring training or at the trade deadline or perhaps later.
Checking in at 6-foot-3 and 230 pounds, Nottingham batted .316/.372/.505 with 17 home runs over 109 games last season between Class A and High-A. He was traded from the Astros to the Athletics as part of the Scott Kazmir deal last July. It’s worth noting that Stearns was the assistant GM for Houston when Nottingham was drafted in the sixth round back in 2013, so he’s clearly a fan.
Giants second baseman Joe Panik missed nearly all of August and September last season due to a nagging back injury, but he told Alex Pavlovic of CSNBayArea.com on Friday that he’s feeling “100 percent.”
Panik, who earned his first All-Star selection last season, originally landed on the disabled list in early August due to what was described as lower back inflammation. He made his return in September, but appeared in just three games before being shut down. The good news is that he was cleared by doctors in mid-December and considers himself “back to normal.”
“It was right around the time of all the signings,” he said, smiling. “I was able to fly under the radar. I got tested and everything had healed up. I got cleared and was able to have my full offseason workouts. I’m good to go. I’m happy to be feeling good and going back out on the field to show that I’m healthy. My swing feels strong.”
Panik altered his offseason workout routine and plans to spend less time in his spikes in the early part of spring training. The hope is that these changes will prevent future issues.
After a strong showing as a rookie in 2014, the 25-year-old Panik proved to be one of the best second baseman in the majors last season by batting .312/.378/.455 with eight home runs and 37 RBI over 100 games while playing solid defense.
Baseball America unveiled their top 100 prospect list Friday night during a special on MLB Network. It should come as no surprise that Dodgers infielder Corey Seager came in at No. 1.
This makes Seager the consensus top prospect in the game. He was also ranked first by MLB.com, Baseball Prospectus, and ESPN’s Keith Law. Twins outfielder Byron Buxton was ranked second on all four lists.
Baseball America has the most aggressive ranking of Cuban infielder Yoan Moncada from the Red Sox, who checked in at No. 3. He was followed by pitching prospects Lucas Giolito from the Nationals and Julio Urias from the Dodgers to round out the top five.
You can see Baseball America’s full top 100 list here.